{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:12:49Z","timestamp":1783930369853,"version":"3.55.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00228-026-04124-5","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T02:44:30Z","timestamp":1781923470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correspondence: Strengthening evidence traceability in written drug promotion to support rational prescribing"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2038-7006","authenticated-orcid":false,"given":"M.","family":"Vijayasimha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8488-6041","authenticated-orcid":false,"given":"M.","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"4124_CR1","doi-asserted-by":"publisher","unstructured":"Alm\u00e5s G, Al Hadidi S, Anderson S, Guelimi R, Afach S, Bettuzzi T et al (2025) Written drug promotion from pharmaceutical companies to general practitioners: adherence to regulations over two decades. Eur J Clin Pharmacol. https:\/\/doi.org\/10.1007\/s00228-025-03951-2","DOI":"10.1007\/s00228-025-03951-2"},{"key":"4124_CR2","doi-asserted-by":"publisher","unstructured":"Mitchell AP, Dusetzina SB, Mishra Meza A, Trivedi NU, Bach PB, Winn AN (2023) Pharmaceutical industry payments and delivery of non-recommended and low-value cancer drugs: population-based cohort study. BMJ 383:e075512. https:\/\/doi.org\/10.1136\/bmj-2023-075512","DOI":"10.1136\/bmj-2023-075512"},{"key":"4124_CR3","doi-asserted-by":"publisher","unstructured":"Persaud S, Al Hadidi, S, Anderson TS (2024) Industry payments to physicians endorsing drugs and devices on a social media platform. JAMA 331(24):2131\u20132134. https:\/\/doi.org\/10.1001\/jama.2024.7832","DOI":"10.1001\/jama.2024.7832"},{"key":"4124_CR4","doi-asserted-by":"publisher","unstructured":"Mor J, Kaur T, Menkes DB, Peter E, Grundy Q (2024) Pharmaceutical industry promotional activities on social media: a scoping review. J Pharm Health Serv Res 15(4):rmae022. https:\/\/doi.org\/10.1093\/jphsr\/rmae022","DOI":"10.1093\/jphsr\/rmae022"},{"key":"4124_CR5","doi-asserted-by":"publisher","unstructured":"Guelimi R, Afach S, Bettuzzi T (2024) Funding and conclusions of network meta-analyses on targeted therapies in inflammatory diseases. J Clin Epidemiol 172:111411. https:\/\/doi.org\/10.1016\/j.jclinepi.2024.111411","DOI":"10.1016\/j.jclinepi.2024.111411"},{"key":"4124_CR6","doi-asserted-by":"publisher","unstructured":"Siena LM (2023) Industry involvement and transparency in the most cited clinical trials, 2019\u20132022. JAMA Netw Open. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.43425","DOI":"10.1001\/jamanetworkopen.2023.43425"},{"key":"4124_CR7","doi-asserted-by":"publisher","unstructured":"Mitchell AP, Sarpatwari A, Bach PB (2022) Industry payments to physicians are kickbacks: how should stakeholders respond? J Health Polit Policy Law 47(6):815\u2013833. https:\/\/doi.org\/10.1215\/03616878-10041205","DOI":"10.1215\/03616878-10041205"},{"key":"4124_CR8","doi-asserted-by":"publisher","unstructured":"Fulone I (2023) Pharmaceutical policies: effects of policies regulating drug marketing. Cochrane Database Syst Rev 6:CD013780. https:\/\/doi.org\/10.1002\/14651858.CD013780.pub2","DOI":"10.1002\/14651858.CD013780.pub2"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04124-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04124-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04124-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:57:26Z","timestamp":1783929446000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04124-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4124"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04124-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"25 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}